PAL also has been shown to predict progression to dementia [19–21, 24] and correlates with AD biomarkers such as cerebrospinal fluid amyloid β and tau [25], hippocampal volume and activation [25, 26], and amyloid β positivity in PET scans [27]. Here, MAPT is linked to Alzheimer disease.